Literature DB >> 8266809

The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms.

K Uvnäs-Moberg1, G Bruzelius, P Alster, T Lundeberg.   

Abstract

The objective of the present study was to investigate whether oxytocinergic mechanisms may contribute to the antinociceptive effect of non-noxious, sensory stimulation. To test this hypothesis, oxytocin levels in plasma and cerebrospinal fluid (CSF) were measured in control rats as well as in rats exposed for 30 min to electro-acupuncture (2 Hz), thermal stimulation (40 degrees C) or vibration (100 Hz). All modes of stimulation induced significant elevations of oxytocin levels in plasma and/or in CSF, 30 or 90 min after the end of stimulation. Secondly, the antinociceptive effects of these treatments were investigated in the tail-flick test with and without prior administration of the oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin (1 mg kg-1 i.p.). All three modes of stimulation caused a significant delay of the tail-flick latency to the same degree as that caused by injection of oxytocin 1 mg kg-1 i.p. (electro-acupuncture P < 0.01, thermal stimulation and vibration P < 0.05). In all cases, the delay was reversed by administration of the oxytocin antagonist (1 mg kg-1 i.p.). These findings suggest that analgesic effects induced by non-noxious sensory stimulation may, in part, be mediated through activation of oxytocinergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266809     DOI: 10.1111/j.1748-1716.1993.tb09612.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  38 in total

1.  Physiological and behavioral responses reveal 9-month-old infants' sensitivity to pleasant touch.

Authors:  Merle T Fairhurst; Line Löken; Tobias Grossmann
Journal:  Psychol Sci       Date:  2014-03-28

Review 2.  Social buffering: relief from stress and anxiety.

Authors:  Takefumi Kikusui; James T Winslow; Yuji Mori
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

3.  The psychobiology of emotion: the role of the oxytocinergic system.

Authors:  Kerstin Uvänas-Moberg; Ingemar Arn; David Magnusson
Journal:  Int J Behav Med       Date:  2005

4.  Tactile stimulation during artificial rearing influences adult function and morphology in a sexually dimorphic neuromuscular system.

Authors:  Kathryn M Lenz; M Dean Graham; Mayte Parada; Alison S Fleming; Dale R Sengelaub; D Ashley Monks
Journal:  Dev Neurobiol       Date:  2008-03       Impact factor: 3.964

5.  Possible involvement of central oxytocin in cisplatin-induced anorexia in rats.

Authors:  Koichi Arase; Hirofumi Hashimoto; Satomi Sonoda; Hiromichi Ueno; Reiko Saito; Yasuhito Motojima; Mitsuhiro Yoshimura; Takashi Maruyama; Keiji Hirata; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2017-06-14       Impact factor: 2.781

6.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

7.  Maternal contact differentially modulates central and peripheral oxytocin in rat pups during a brief regime of mother-pup interaction that induces a filial huddling preference.

Authors:  S Kojima; R A Stewart; G E Demas; J R Alberts
Journal:  J Neuroendocrinol       Date:  2012-05       Impact factor: 3.627

8.  Skin-to-skin contact (Kangaroo Care) analgesia for preterm infant heel stick.

Authors:  Susan M Ludington-Hoe; Robert Hosseini; Deborah L Torowicz
Journal:  AACN Clin Issues       Date:  2005 Jul-Sep

Review 9.  Oxytocin - a multifunctional analgesic for chronic deep tissue pain.

Authors:  Burel R Goodin; Timothy J Ness; Meredith T Robbins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

10.  Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects.

Authors:  Russell E Poland; Lev Gertsik; Joya T Favreau; Shawnee I Smith; James M Mirocha; Uma Rao; Eric S Daar
Journal:  J Altern Complement Med       Date:  2012-10-25       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.